The presence of ISR and unfolded protein response in postmortem human brains (Scheper & Hoozemans, 2015) does not indicate evidently when this process has started in AD patients but is an indication that targeting PKR as early as possible might contribute to attenuate many detrimental consequences of PKR activation in affected individuals. Here, EIF2AK2 is linked to Alzheimer disease.